Take Solutions Q2 FY27 Outlook: What The Post-Demerger Numbers Show

TAKE trades near Rs16.07. Post-demerger entity, much smaller than its pre-2019 scale. Core operating profit has stayed negative across all five quarters shown.

Track the latest Take Solutions Ltd. share price on Univest. As with the rest of this Take Solutions Q2 results preview, the numbers cited are drawn from public filings.

The Take Solutions Q2 results for the September 2026 quarter (Q2 FY27) have not yet been announced, and this preview is built entirely from figures the company has already reported for Jun25 through Jun26. Take Solutions Ltd. is the smaller entity that has existed since the group’s life-sciences business demerger years ago, and that history matters for how its results should be read. This Take Solutions Q2 results outlook is based only on historical, already-reported figures. This Take Solutions Q2 results outlook is based only on historical, already-reported figures.

Open a Univest demat account to track TAKE ahead of its Q2 FY27 results.

Take Solutions Q2 Results Date

As of now, no board meeting or results date has been disclosed by Take Solutions Ltd. for Q2 FY27. Companies typically report their September-quarter results in the October to November window, and this has broadly been the pattern for Take Solutions historically. The confirmed TAKE Q2 results date should be checked through official NSE and BSE announcements closer to that period. Readers following the Take Solutions Q2 results should note that no forward estimate is implied here. Readers following the Take Solutions Q2 results should note that no forward estimate is implied here.

Take Solutions Q2 Results Expectations

Also read – Camlin Fine Sciences Q2 Results FY27 Preview

A critical starting point for Take Solutions Q2 Results Expectations is that historical comparisons to the company’s pre-demerger scale are not meaningful. Take Solutions Ltd. today is a much smaller entity than it was before its life-sciences business was demerged, so any comparison of current results should only be made against the post-demerger quarters shown here, from Jun25 through Jun26, and not against the company’s much larger historical revenue base from years ago. The Take Solutions Q2 results discussion above draws entirely on numbers the company has already disclosed. The Take Solutions Q2 results discussion above draws entirely on numbers the company has already disclosed.

Within that post-demerger window, core operating profit has been negative in every quarter: negative Rs0.44cr in Jun25, negative Rs0.3cr in Sep25, negative Rs0.35cr in Dec25, negative Rs0.82cr in Mar26 and negative Rs0.27cr in Jun26. This is a factual, recurring pattern rather than an occasional dip, and there is no data-driven basis in the historical numbers to expect a shift to positive core operating profit in the Sep 2026 quarter. Reported revenue was effectively nil in the first three quarters shown before jumping to Rs54.19cr in Mar26 and Rs30.37cr in Jun26, a change worth noting though not one this preview can explain from the data alone. For context on the Take Solutions Q2 results, the preceding quarterly figures are all historical, not projected. For context on the Take Solutions Q2 results, the preceding quarterly figures are all historical, not projected.

Previous Quarter (Q1 FY27, Jun 2026) Performance

In Jun26, Take Solutions Ltd. reported revenue of Rs30.37cr, an operating loss of Rs0.27cr at an operating margin of negative 0.89%, and net profit of Rs1.06cr. Net profit remained positive in this quarter despite the operating loss, consistent with the pattern where non-operating or other income items, not core operations, have driven the bottom line. This section of the Take Solutions Q2 results coverage relies solely on reported data, not analyst forecasts. This section of the Take Solutions Q2 results coverage relies solely on reported data, not analyst forecasts.

Q2 FY26 (Sep 2025) Base Quarter

The year-ago base quarter, Sep25 or Q2 FY26, showed revenue of effectively Rs0, an operating loss of Rs0.3cr, and net profit of Rs6.29cr. Operating margin is Not meaningful for this quarter given the near-zero reported revenue base. As with the other quarters, the Sep25 net profit figure was well above what the operating loss would imply, pointing again to other income or exceptional items as the driver rather than core operations. The Take Solutions Q2 results trend described here reflects only what has already been reported to exchanges.

Recent Trend: Jun25 Through Jun26

Across the five quarters shown, core operating profit has stayed negative throughout, ranging from negative Rs0.27cr to negative Rs0.82cr, while net profit has swung between a loss of Rs0.91cr in Jun25 and a gain of Rs6.29cr in Sep25, before settling at Rs1.11cr in Dec25, Rs4.36cr in Mar26 and Rs1.06cr in Jun26. This pattern should be stated factually rather than framed as an operating turnaround: the swings in net profit have consistently come from other income or non-operating items, not from an improvement in the underlying operating business, which has remained loss-making in every single quarter of this window. Any reader researching the Take Solutions Q2 results should treat the figures above as historical reference points.

Key Factors To Watch

For Q2 FY27, the most relevant factor is whether core operating profit continues its established negative pattern or shows any change, and how large a role other income or exceptional items play in the eventual net profit figure, given that this has been the dominant driver of the bottom line in every quarter on record. The recent jump in reported revenue seen in Mar26 and Jun26, compared with the near-zero figures in the three quarters before that, is also worth watching for continuation or reversal. As with the rest of this Take Solutions Q2 results preview, the numbers cited are drawn from public filings.

Also read – Campus Activewear Q2 Results FY27 Preview

Valuation

TAKE currently trades at around Rs16.07, with a trailing PE of 40.17 and a price-to-book ratio of 7.65 against a book value of about Rs2.1 per share. Return on equity is 16.5%, and debt-to-equity is 0.0, indicating the company carries no meaningful debt. Dividend yield is 0.0%. The stock’s 52-week range spans Rs10.11 to Rs50.14, a wide band that reflects its small size, with the 50-day moving average at Rs19.32 and the 200-day moving average at Rs32.63, both well above the current price, and an RSI of 61.42. Market capitalisation is approximately Rs237cr. Given the company’s negative core operating profit and its reliance on other income, valuation multiples such as PE should be read with caution here. This Take Solutions Q2 results outlook is based only on historical, already-reported figures.

What To Watch In The Q2 FY27 Results

Once results are filed, the points worth tracking are whether the operating loss narrows from the negative Rs0.27cr seen in Jun26, whether reported revenue stays near the Rs30cr level seen in the last two quarters or reverts toward the earlier near-zero figures, and the scale of any other income or exceptional items feeding into net profit. As always, only the filed results themselves will confirm these outcomes. Readers following the Take Solutions Q2 results should note that no forward estimate is implied here.

Conclusion

Take Solutions heads into its Q2 FY27 results as a small, post-demerger entity whose core operations have remained loss-making across every quarter shown, with net profit driven by other income rather than by an operating turnaround. Comparisons to the company’s much larger pre-demerger history are not meaningful. This preview reflects only already-reported data through Jun26, ahead of a results date that has not been confirmed. The Take Solutions Q2 results discussion above draws entirely on numbers the company has already disclosed.

Track small-cap names like TAKE by opening a free Univest account.

Create your Univest demat account to stay updated on TAKE’s next filing.

Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Data cited is drawn from publicly reported company filings and may be subject to revision; readers should verify all figures independently with NSE, BSE, or the company’s official disclosures before making any decision. Univest is a SEBI-registered Research Analyst, registration number INH000013776. Investments in securities are subject to market risk, and past performance is not indicative of future results. Please consult a SEBI-registered financial advisor before investing.

When is the Take Solutions Q2 results date for FY27?

Ans. No date has been announced yet. Take Solutions typically reports its September-quarter results in the October to November window, so the confirmed date should be checked via NSE and BSE filings closer to that period. For context on the Take Solutions Q2 results, the preceding quarterly figures are all historical, not projected.

Is Take Solutions comparable to its pre-demerger scale?

Ans. No. Take Solutions Ltd. is the smaller entity that has existed since the group’s life-sciences business demerger years ago, so historical comparisons to its pre-demerger scale are not meaningful, only post-demerger quarters should be compared. This section of the Take Solutions Q2 results coverage relies solely on reported data, not analyst forecasts.

Is Take Solutions’ core operating profit positive?

Ans. No, core operating profit has been negative in every quarter shown from Jun25 through Jun26, ranging from negative Rs0.27cr to negative Rs0.82cr. The Take Solutions Q2 results trend described here reflects only what has already been reported to exchanges.

What drives Take Solutions’ net profit swings?

Ans. Net profit swings across the last five quarters have been driven by other income and non-operating items rather than by core operations, which have remained loss-making throughout. Any reader researching the Take Solutions Q2 results should treat the figures above as historical reference points.